A critical discovery in cancer research is occurring with the use of mini-antibodies to re-engage damaged p53. This crucial malignant inhibitor protein is frequently disabled in various kinds of cancer, leading https://bookmarklinking.com/story347955/mini-antibodies-reactivate-the-p53-protein-a-potential-approach-for-cancer-therapy